Log In
Print
BCIQ
Print
Print this Print this
 

Lumacan, hexaminolevulinate

  Manage Alerts
Collapse Summary General Information
Company Photocure ASA
DescriptionFluorescence-based photodynamic diagnostic (PDD) product
Molecular Target
Mechanism of ActionDiagnostic; Photodynamic therapy
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase I/II
Standard IndicationCancer, Diagnostic
Indication DetailsDetect precancerous lesions in the colon
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$130.5M

$4.0M

$126.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today